MeiraGTx Holdings plc Ordinary Shares (MGTX) Dividend History

MeiraGTx Holdings plc is a clinical-stage gene therapy company focused on developing treatments for rare and serious diseases. Based in the UK, the company specializes in creating advanced gene therapy products using proprietary platforms to deliver potentially curative therapies for conditions such as neurological, ophthalmic, and infectious diseases.

450 East 29th Street, New York, NY, 10016
Phone: (646) 490-2965
Website: https://www.meiragtx.com

Dividend History

MeiraGTx Holdings plc Ordinary Shares currently does not pay dividends

Company News

  • Coave Therapeutics, a company pioneering genetic medicines, has established a new Scientific Advisory Board (SAB) with renowned experts in AAV vector biology, gene therapy for ophthalmology and CNS diseases, and extra-hepatic gene delivery. The SAB will provide strategic guidance to support Coave's R&D initiatives and the development of its ALIGATER platform.

    GlobeNewswire Inc.
    Featured Companies: RGNX
  • CRISPR Therapeutics (CRSP) delivered earnings and revenue surprises of 12.27% and 93.94%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

    Zacks Investment Research
    Featured Companies: CRSP
  • Shares of CarMax, Inc. (NYSE: KMX) moved higher during Thursday’s session following better-than-expected quarterly earnings. KMX reported a third-quarter sales decline of 5.5% year-on-year to $6.15 billion, missing the analyst consensus estimate of $6.33 billion. EPS of $0.52 beat the consensus estimate of $0.44. CarMax shares climbed 7.7% to $80.42 on Thursday. Here are some other stocks moving in today's mid-day session. Gainers Infrared Cameras Holdings Inc (NASDAQ: MSAI) shares jumped 222% to $8.43 after falling over 61% on Wednesday. HOOKIPA Pharma Inc. (NASDAQ: HOOK) surged 75% to $0.9874 after the company announced a $21.25 million equity investment from Gilead Sciences. DMK Pharmaceuticals Corporation (NASDAQ: DMK) shares climbed 50.8% to $0.8899. DMK Pharmaceuticals regained full rights to commercialize ZIMHI after the termination of an exclusive commercialization and distribution with US WorldMeds, LLC. PetVivo Holdings, Inc. (NASDAQ: PETV) shares rose 41.3% to $1.20. ParaZero Technologies Ltd. (NASDAQ: PRZO) shares climbed 37.4% to $1.6904 after the company appointed Nir Ben Moshe, a former senior director in the Israeli Ministry of Defense, as a specialist advisor. Annexon, Inc. (NASDAQ: ANNX) gained 34.7% to $3.88. Annexon outlined its global registrational program for ANX007 for the treatment of patients with geographic atrophy. The company also reported pricing of $125 million public offering of common stock. Triumph Group, Inc. (NYSE: TGI) rose 27% to $15.59 after the company entered into a definitive agreement with AAR to sell its Product Support business. Aurora Technology Acquisition Corp.. (NASDAQ: ATAK) shares gained 26.3% to $5.57 after falling 15% on Wednesday. Galiano Gold Inc. (NYSE: GAU) rose 23.5% to $0.8130 as the company announced that it has entered into a binding share purchase agreement with subsidiaries of Gold Fields Limited. Calliditas Therapeutics AB (NASDAQ:

    Benzinga
  • Sanofi may use company's gene regulation technology in immunology, metabolic disease and other conditions

    MarketWatch
  • Listen on the go! A daily podcast of Wall Street Breakfast's Alpha Talks will be available this morning. on Seeking Alpha, iTunes, Stitcher and Spotify.

    Seeking Alpha
Page data last updated 07/23/2025 16:16:25 UTC